Speaker illustration

Doctor C Michael Gibson

Harvard Medical School, Boston (United States of America)

C. Michael Gibson, M.S., M.D. is an interventional cardiologist, cardiovascular researcher & educator. He is the CEO of the combined non-profit Baim and PERFUSE research institutes at Harvard Medical School. The institutes have led over 1,000 studies, published 3,000 manuscripts in the peer review literature, and have led 60 FDA submissions from their network of 7,000 sites worldwide. In 2014, 2018 - 2020 Gibson was ranked as one of the world's most highly cited authors in all of science in the past decade by Thomson Reuters. His work has been cited over 107,000 times, and he has an H index of 118 and an i10-index of 469. Dr. Gibson obtained his BS, MS, and MD degrees at the University of Chicago where he was a Phi Beta Kappa and AOA graduate.

Plaque erosion: an important mechanism of ACS: current concepts and contemporary management

Event: ESC Congress 2022

Topic: Acute Coronary Syndromes

Session type: Symposium

Thumbnail

HOT LINE SESSION 5

Event: ESC Congress 2022

Topic: European Society of Cardiology

Session type: Hot Line

Thumbnail

Guidelines in Practice: antithrombotic therapy in atrial fibrillation and acute myocardial infarction

Event: ESC Congress 2021 - The Digital Experience

Topic: Interventional Cardiology

Session type: Guidelines in Practice

Thumbnail

Coronary artery disease - Epidermiology, prognosis and outcome

Event: ESC CONGRESS 2019

Topic: Epidemiology, Prognosis, Outcome

Session type: Rapid Fire Abstracts

Thumbnail

Be scientific and unique on Twitter

Event: ESC CONGRESS 2019

Topic: European Society of Cardiology, Other

Session type: Professional Development

Thumbnail

Cardiovascular innovation: the next frontier

Event: ESC CONGRESS 2019

Topic: Hospital Information Systems, Electronic Medical Records, Clinical Decision Support

Session type: Symposium

Thumbnail

The ORION Program - What to look for in ORION-11

Event: ESC CONGRESS 2019

Topic: Coronary Artery Disease

Session type: Satellite Symposium

Thumbnail

High sensitivity troponins in patients with suspected acute coronary syndromes

Event: ESC CONGRESS 2019

Topic: Epidemiology, Prognosis, Outcome

Session type: Advances in Science

Thumbnail

Twitter Influencers get social at #ESCCongress

Event: ESC CONGRESS 2019

Topic: European Society of Cardiology, Other

Session type: Professional Development

Thumbnail

Cardiology 10 years from now - My predictions and how to get yourself ready

Event: ESC Congress 2018

Topic: Training and Education

Session type: Symposium

Thumbnail

ESC 365 is supported by

logo Novo Nordisk